FWI
BMY icon

Facet Wealth Inc’s Bristol-Myers Squibb BMY Stock Holding History

Facet Wealth Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$389K Buy
+6,418
New +$374K 0.01% 208

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Facet Wealth Inc's BMY Position: Q1 2026 in Review

Facet Wealth Inc opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 6,418 shares worth $389K. The stake represents 0.01% of the portfolio and ranks #208 among its holdings.

2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Facet Wealth Inc held 6,418 shares of Bristol-Myers Squibb worth $389K as of Q1 2026.
  • Bristol-Myers Squibb was a new Facet Wealth Inc position in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of Facet Wealth Inc's portfolio in Q1 2026, its #208 holding.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Facet Wealth Inc's 13F filing for Q1 2026, filed 7 May 2026.